Stage III Pleural Diffuse Malignant Mesothelioma AJCC v8
Oncology
Prevalence
1.0 / 100K
Incidence
0.9 / 100K/yr
0 drugs in development·0 companies·0 clinical trials
Deep-dive into Stage III Pleural Diffuse Malignant Mesothelioma AJCC v8
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis